SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022233
Filing Date
2022-11-04
Accepted
2022-11-04 17:28:42
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20220930.htm   iXBRL 10-Q 4491545
2 EX-31.1 vtyx-ex31_1.htm EX-31.1 22985
3 EX-31.2 vtyx-ex31_2.htm EX-31.2 23006
4 EX-32.1 vtyx-ex32_1.htm EX-32.1 14048
5 EX-32.2 vtyx-ex32_2.htm EX-32.2 14069
  Complete submission text file 0000950170-22-022233.txt   13069023

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtyx-20220930_cal.xml EX-101.CAL 52911
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20220930_lab.xml EX-101.LAB 479259
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20220930.xsd EX-101.SCH 53792
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20220930_pre.xml EX-101.PRE 378956
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtyx-20220930_def.xml EX-101.DEF 231193
66 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20220930_htm.xml XML 2600430
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 221363169
SIC: 2834 Pharmaceutical Preparations